Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Allmercap Mercaptopurine 20mg/mL Oral suspension Link Pharmaceuticals Limited Nova Laboratories Limited, Leicester, United Kingdom
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Carvedilol Carvedilol 3.125mg Tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Carvedilol Carvedilol 6.25mg Tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Carvedilol Carvedilol 12.5mg Tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Carvedilol Carvedilol 25mg Tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Brilinta Ticagrelor 60mg Film coated tablet AstraZeneca Limited AstraZeneca AB, Sodertalje, Sweden
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Brimica Genuair Aclidinium bromide 0.4mg equivalent to aclidinium 0.34mg Formoterol fumarate dihydrate 0.012mg Powder for inhalation A. Menarini New Zealand Pty Limited Industrias Farmaceuticas Almirall SA (IFA), Barcelona, Spain
|
Dated this 15th day of November 2016.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).